Emtricitabine And Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 64380-719

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 64380-719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fdb51943 Ef13 4b48 A4fd C64138e73436 01)

Chemical structure of the active ingredients Emtricitabine and Tenofovir Disoproxil Fumarate, depicted as a molecular formula diagram showing atoms and bonds.*

FDA Label Image

Structure (Fdb51943 Ef13 4b48 A4fd C64138e73436 02)

Chemical structure of Tenofovir Disoproxil Fumarate, the active ingredient in the product Emtricitabine and Tenofovir Disoproxil Fumarate oral tablets by Strides Pharma Science Limited.*

FDA Label Image

Container (Fdb51943 Ef13 4b48 A4fd C64138e73436 03)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg / 300 mg, oral film-coated tablets. The label states 30 tablets per container, manufactured by Strides Pharma Science Limited and distributed by Strides Pharma Inc. It includes storage instructions, barcode, NDC 64380-719-04, and a note to dispense the patient Medication Guide with each dispensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.